Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X A Alvarez

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1997
Anapsos reverses interleukin-1 beta overexpression and behavioral deficits in nbM-lesioned ratsX A Alvarez, A Franco-Maside, R Zas, et al.
Methods and Findings in Experimental and Clinical Pharmacology|July 1, 1990
Antagonistic effects of growth hormone-releasing factor (GRF) and somatostatin on locomotor activity: GRF-induced hyperkinetic syndromeR Cacabelos, H Niigawa, X A Alvarez, et al.
Annals of the New York Academy of Sciences|January 17, 1996
Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factorsR Cacabelos, J Caamaño, M J Gómez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|March 1, 1994
Brain interleukin-1 beta in Alzheimer's disease and vascular dementiaR Cacabelos, X A Alvarez, L Fernández-Novoa, et al.
Annals of the New York Academy of Sciences|November 5, 1997
APOE epsilon 4 allele frequency in Alzheimer's disease and vascular dementia in the Spanish populationK Beyer, J I Lao, L Fernández-Novoa, et al.
European Journal of Neurology|May 27, 2010
Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of CerebrolysinX A Alvarez, R Cacabelos, C Sampedro, et al.
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1996
Effects of S-9977-2 on histamine levels in ratsL Fernández-Novoa, X A Alvarez, S Détolle-Sarbach, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 2005
Neuropeptide dietary supplement N-PEP-12 enhances cognitive function and activates brain bioelectrical activity in healthy elderly subjectsX A Alvarez, L Corzo, M Laredo, et al.
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1997
Citicoline improves memory performance in elderly subjectsX A Alvarez, M Laredo, D Corzo, et al.
Annals of the New York Academy of Sciences|November 5, 1997
Cerebrovascular changes associated with interleukin-1 beta (IL-1 beta) and histamine (HA) levels in Alzheimer's diseaseX A Alvarez, L Fernández-Novoa, J Caamaño, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1997
Anapsos reverses interleukin-1 beta overexpression and behavioral deficits in nbM-lesioned ratsX A Alvarez, A Franco-Maside, R Zas, et al.
Methods and Findings in Experimental and Clinical Pharmacology|July 1, 1990
Antagonistic effects of growth hormone-releasing factor (GRF) and somatostatin on locomotor activity: GRF-induced hyperkinetic syndromeR Cacabelos, H Niigawa, X A Alvarez, et al.
Annals of the New York Academy of Sciences|January 17, 1996
Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factorsR Cacabelos, J Caamaño, M J Gómez, et al.
Methods and Findings in Experimental and Clinical Pharmacology|March 1, 1994
Brain interleukin-1 beta in Alzheimer's disease and vascular dementiaR Cacabelos, X A Alvarez, L Fernández-Novoa, et al.
Annals of the New York Academy of Sciences|November 5, 1997
APOE epsilon 4 allele frequency in Alzheimer's disease and vascular dementia in the Spanish populationK Beyer, J I Lao, L Fernández-Novoa, et al.
European Journal of Neurology|May 27, 2010
Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of CerebrolysinX A Alvarez, R Cacabelos, C Sampedro, et al.
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1996
Effects of S-9977-2 on histamine levels in ratsL Fernández-Novoa, X A Alvarez, S Détolle-Sarbach, et al.
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 2005
Neuropeptide dietary supplement N-PEP-12 enhances cognitive function and activates brain bioelectrical activity in healthy elderly subjectsX A Alvarez, L Corzo, M Laredo, et al.
Methods and Findings in Experimental and Clinical Pharmacology|April 1, 1997
Citicoline improves memory performance in elderly subjectsX A Alvarez, M Laredo, D Corzo, et al.
Annals of the New York Academy of Sciences|November 5, 1997
Cerebrovascular changes associated with interleukin-1 beta (IL-1 beta) and histamine (HA) levels in Alzheimer's diseaseX A Alvarez, L Fernández-Novoa, J Caamaño, et al.
Pageof 4